Gain in net survival from hypertension control over the last half-century

Référence de l’article :  Pierre Lantelme et al. European Journal of Preventive Cardiology 2021. doi:10.1093/eurjpc/zwab094 Lecture proposée par : P Lantelme et M Lopez-Sublet L’objectif de cette étude a été de déterminer si les améliorations apportées à la prise en charge de l’hypertension artérielle en France au cours des cinq dernières décennies, ont influencé le pronostic des sujets. L’analyse a portée sur…

Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who, What, and How?: A Scientific Statement From the American Heart Association. Hypertension

Référence de l’article : Barone Gibbs B, Hivert MF, Jerome GJ, Kraus WE, Rosenkranz SK, Schorr EN, Spartano NL, Lobelo F; American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. Physical Activity as a Critical Component of First-Line Treatment for Elevated Blood Pressure or Cholesterol: Who,…

Effect of the Million Hearts Cardiovascular Disease Risk Reduction Model on Initiating and Intensifying Medications: A Prespecified Secondary Analysis of a Randomized Clinical Trial

Référence de l’article : Peterson GG, Pu J, Magid DJ, et al. Effect of the Million Hearts Cardiovascular Disease Risk Reduction Model on Initiating and Intensifying Medications: A Prespecified Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol. Published online June 02, 2021. doi:10.1001/jamacardio.2021.1565 Lecture proposée par : JP Fauvel The Million Hearts® Cardiovascular Disease Risk Reduction est une étude…

Final Report of a Trial of Intensive versus Standard Blood-Pressure Control

Référence de l’article : SPRINT Research Group, Lewis CE, et al. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2021 May 20;384(20):1921-1930. doi: 10.1056/NEJMoa1901281. PMID: 34010531. Lecture proposée par : JP Fauvel Voici les résultats finaux de SPRINT qui a randomisé 9361 hypertendus présentant un risque accru de maladie CV (sans diabète ni…

Adrenocorticotropic Hormone-Stimulated Adrenal Venous Sampling Underestimates Surgically Curable Primary Aldosteronism: A Retrospective Cohort Study and Review of Contemporary Studies

Référence de l’article : Yozamp N, Hundemer GL, Moussa M, Underhill J, Fudim T, Sacks B, Vaidya A. Adrenocorticotropic Hormone-Stimulated Adrenal Venous Sampling Underestimates Surgically Curable Primary Aldosteronism: A Retrospective Cohort Study and Review of Contemporary Studies. Hypertension. 2021 May 17:HYPERTENSIONAHA12117248. doi: 10.1161/HYPERTENSIONAHA.121.17248. Epub ahead of print. PMID: 33993726. Lecture proposée par : L Amar Le cathétérisme des…

Association between antihypertensive treatment and adverse events: systematic review and meta-analysis

Référence de l’article : Albasri A, Hattle M, Koshiaris C, Dunnigan A, Paxton B, Fox S E et al. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis BMJ 2021; 372 :n189 doi:10.1136/bmj.n189 Lecture proposée par : JP Fauvel Une méta-analyse portant sur les effets secondaires des traitements anti-hypertenseurs a été publiée dans le BMJ. Le critère…

Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients

Référence de l’article : Semenzato L, Botton J, Drouin J, Baricault B, Vabre C, Cuenot F, Penso L, Herlemont P, Sbidian E, Weill A, Dray-Spira R, Zureik M. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients. Hypertension. 2021 Mar 3;77(3):833-842. doi: 10.1161/HYPERTENSIONAHA.120.16314. Epub 2021 Jan 11. PMID: 33423528. Lecture proposée par : JP…

Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5

Référence de l’article : Gregg LP, Hedayati SS, Yang H, Van Buren PN, Banerjee S, Navaneethan SD, Virani SS, Winkelmayer WC, Alvarez CA. Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5. Hypertension. 2021 Mar 3;77(3):948-959. doi: 10.1161/HYPERTENSIONAHA.120.16117. Epub 2021 Jan 11. PMID: 33423525; PMCID: PMC7878423. Lecture proposée…

Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial.

Référence de l’article : Lopes RD, Macedo AVS, de Barros E Silva PGM, et al. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. JAMA. 2021;325(3):254–264. doi:10.1001/jama.2020.25864 Résumé proposé par : JP Fauvel   Dans cet essai clinique randomisé multicentrique…

First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: cohort study in UK primary care

Référence de l’article : Sinnott Sarah-Jo, Douglas Ian J, Smeeth Liam, Williamson Elizabeth, Tomlinson Laurie A. First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: cohort study in UK primary care BMJ 2020; 371 :m4080 Résumé proposé par : JP Fauvel  Cette étude publiée dans le BMJ avait pour but de…